Retevmo (selpercatinib capsules and tablets - Eli Lilly) — Cigna
Non-Small Cell Lung Cancer
Initial criteria
- Patient is age ≥ 18 years
- Patient has recurrent, advanced, or metastatic disease
- Tumor is rearranged during transfection (RET) fusion-positive
Approval duration
1 year